Literature DB >> 10814712

A novel protein with RNA-binding motifs interacts with ataxin-2.

H Shibata1, D P Huynh, S M Pulst.   

Abstract

Spinocerebellar ataxia type 2 (SCA2) is caused by expansion of a polyglutamine tract in ataxin-2, a protein of unknown function. Using the yeast two-hybrid system, we identified a novel protein, A2BP1 (ataxin-2 binding protein 1) which binds to the C-terminus of ataxin-2. Northern blot analysis showed that A2BP1 was predominantly expressed in muscle and brain. By immunocfluorescent staining, A2BP1 and ataxin-2 were both localized to the trans -Golgi network. Immunocytochemistry showed that A2BP1 was expressed in the cytoplasm of Purkinje cells and dentate neurons in a pattern similar to that seen for ataxin-2 labeling. Western blot analysis of subcellular fractions indicated enrichment of A2BP1 in the same fractions as ataxin-2. Sequence analysis of the A2BP1 cDNA revealed an RNP motif that is highly conserved among RNA-binding proteins. A2BP1 had striking homology with a human cDNA clone, P83A20, of unknown function and at least two copies of A2BP1 homologs are found in the Caenorhabditis elegans genome database. A2BP1 and related proteins appear to form a novel gene family sharing RNA-binding motifs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814712     DOI: 10.1093/hmg/9.9.1303

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  105 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2.

Authors:  Shuying Sun; Zuo Zhang; Oliver Fregoso; Adrian R Krainer
Journal:  RNA       Date:  2011-12-19       Impact factor: 4.942

3.  Drosophila ataxin 2-binding protein 1 marks an intermediate step in the molecular differentiation of female germline cysts.

Authors:  Omür Y Tastan; Jean Z Maines; Yun Li; Dennis M McKearin; Michael Buszczak
Journal:  Development       Date:  2010-08-19       Impact factor: 6.868

4.  MiR-980 Is a Memory Suppressor MicroRNA that Regulates the Autism-Susceptibility Gene A2bp1.

Authors:  Tugba Guven-Ozkan; Germain U Busto; Soleil S Schutte; Isaac Cervantes-Sandoval; Diane K O'Dowd; Ronald L Davis
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

Review 5.  RNA protein interaction in neurons.

Authors:  Robert B Darnell
Journal:  Annu Rev Neurosci       Date:  2013-05-20       Impact factor: 12.449

6.  Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Authors:  A R Paciorkowski; Y Shafrir; J Hrivnak; M C Patterson; M B Tennison; H B Clark; C M Gomez
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

7.  Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges.

Authors:  Michael T Lovci; Dana Ghanem; Henry Marr; Justin Arnold; Sherry Gee; Marilyn Parra; Tiffany Y Liang; Thomas J Stark; Lauren T Gehman; Shawn Hoon; Katlin B Massirer; Gabriel A Pratt; Douglas L Black; Joe W Gray; John G Conboy; Gene W Yeo
Journal:  Nat Struct Mol Biol       Date:  2013-11-10       Impact factor: 15.369

8.  Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.

Authors:  Guangbin Xia; Katherine Santostefano; Takashi Hamazaki; Jilin Liu; S H Subramony; Naohiro Terada; Tetsuo Ashizawa
Journal:  J Mol Neurosci       Date:  2012-12-09       Impact factor: 3.444

9.  Repression of Pumilio Protein Expression by Rbfox1 Promotes Germ Cell Differentiation.

Authors:  Arnaldo Carreira-Rosario; Varsha Bhargava; Jens Hillebrand; Rahul K Kollipara; Mani Ramaswami; Michael Buszczak
Journal:  Dev Cell       Date:  2016-03-07       Impact factor: 12.270

10.  A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG.

Authors:  Yui Jin; Hitoshi Suzuki; Shingo Maegawa; Hitoshi Endo; Sumio Sugano; Katsuyuki Hashimoto; Kunio Yasuda; Kunio Inoue
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.